Johns Hopkins University
- Johns Hopkins University
Background The Day at the Market Program (D@M) is a Johns Hopkins University community outreach initiative which provides an avenue for academic researchers, community-based organizations, and other interested parties (herein referred to as vendors) to meet community members within the city’s historic public markets and other community sites. We share our experience with bi-directional community
- Trial Innovation NetworkUniversity Of UtahVanderbilt University Medical CenterTufts University BostonJohns Hopkins UniversityDuke University
Daniel Benjamin, MD, PhD, MPH1; Gordon R. Bernard, MD2; J. Michael Dean, MD, MBA3; Daniel E. Ford, MD, MPH4; Daniel Hanley, MD4; Paul A. Harris, PhD, FACMI2; Harry Selker, MD, MSPH5; Consuelo H. Wilkins, MD, MSCI2 1Duke Clinical Research Institute, 2Vanderbilt Institute for Clinical and Translational Research, 3University of Utah, 4Johns Hopkins University, 5Tufts University ABSTRACT: The Trial
-Johns Hopkins UniversityThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-
-Johns Hopkins University
The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-
-Johns Hopkins UniversityThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-Johns Hopkins UniversityAs a follow-up to the 2021 Un-Meeting: Exploring the Inclusion of Community Hospitals in Clinical Research, the CLIC Un-Meetings Team is hosting a webinar of a successful academic – community hospital partnership. Join Dr. Adrian Sandra Dobs, director of the Johns Hopkins Clinical Research Network and professor of Medicine and Oncology, for a 20-minute live Zoom webinar on the topic of- Johns Hopkins University
BACKGROUND Researchers have had to explore new modes of patient identification and recruitment due to the restrictions and resource limitations caused by the COVID-19 pandemic. Electronic health record (EHR)-based participant identification and recruitment through patient portal messaging offer potential solutions to help researchers meet recruitment goals without the additional risk of in-person
-
-Johns Hopkins University
Jo Ellen Wilson, MD, MPH, visiting KL2 scholar from Vanderbilt University, will be hosted by the Johns Hopkins Clinical Research Scholars (KL2) Program. Dr. Wilson will be presenting her work on "Disentangling Acute Brain Dysfunction in the ICU: Current Progress and Future Direction".
-
-Johns Hopkins University
Lavanya Vasudevan, PhD, MPH, visiting KL2 scholar from Duke University, will be hosted by the Johns Hopkins International Vaccine Access Center in the lead up to World Immunization Week. Dr. Vasudevan will be presenting her work on "Addressing Global Vaccine Hesitancy - Challenges & Opportunities".
Focal and Segmental Glomerulosclerosis, Minimal Change Disease, and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in
The Brain Vascular Malformation Consortium (BVMC) focuses on three rare brain conditions: familial cerebral cavernous malformation (CCM), Sturge-Weber syndrome (SWS), and hereditary hemorrhagic telangiectasia (HHT). These disorders are poorly understood, costly to manage, and can cause serious complications such as hemorrhages, seizures, and problems with spinal cord, nerve or brain function. Over
Virginia Commonwealth UniversityUniversity of Nebraska Medical CenterUniversity Of WashingtonUniversity Of Alabama At BirminghamUniversity Of North Carolina Chapel HillJohns Hopkins UniversityMayo ClinicOregon Health and Science UniversityMany clinical questions have arisen with the COVID-19 pandemic, from who is at greatest risk for COVID-19 infection to adverse outcomes if infected to how COVID-19 has impacted healthcare utilization patterns. To help answer these questions, and many more, the National COVID Cohort Collaborative (N3C) has integrated real-world clinical observations from across the nation into a harmonized database
-Johns Hopkins UniversityPlease tune in Saturday, October 24 at noon, for a special one hour video screening of the Henrietta Lacks Memorial Lecture: 100 Years of Henrietta Lacks. This year, the impact of coronavirus has significantly changed how we currently live, work and communicate as a community. 2020 also marks 100 years of celebrating the life of a remarkable woman, Mrs. Henrietta Lacks. During this challenging
Johns Hopkins UniversityBuilding Capacity for Rapid COVID-19 Scientific Research Cheryl Dennison Himmelfarb RN PhD, Suzanne Jan de Beur MD, Cassie Lewis Land MS, Dan Ford MD MPH, Mark Sulkowski MD The Johns Hopkins Institute for Clinical and Translational Research, Johns Hopkins University, Baltimore, Maryland Background: The Johns Hopkins Health System (JHHS) and University has led a robust response to the COVID-19
-Johns Hopkins UniversityThere are now more than 33 million confirmed COVID-19 cases worldwide and the death toll of the global pandemic is nearing 1 million. The United States remains the most affected country, with more than 7 million diagnosed COVID-19 infections and upwards of 200,000 deaths to date. The pandemic has also had enormous social and economic impacts globally, and continues to challenge families
-Johns Hopkins UniversityThe June HOT meeting will cover the Protégé plug-in tool and “caDSR on FHIR”, with insight from the CD2H ACT enhancement project. The HOT team is building a FHIR terminology service that focuses on value sets from data elements and value domains in the NCI cancer Data Standards Registry and Repository (caDSR). Guest speakers this month include Dr. Gilberto Fragoso (NCI Center for Biomedical
May 18, 2020More than 400 randomized clinical trials (RCTs) have been registered on clinicaltrials.gov, many are meant to answer similar questions but lack any method to combine data and evidence. By aggregating evidence across these trials, we can learn about interventions for COVID-19 as quickly and reliably as possible. The COVID-19 Collaboration Platform brings disparate research teams working on the same
Johns Hopkins UniversityThe Center for Systems Science and Engineering (CSSE) at Johns Hopkins University has created an interactive web-based dashboard to visualize and track reported cases in real-time. It is created in Arcgis.
- February 26, 2020
Research symposium at Johns Hopkins explores how clinicians can get the most out of advancements in digital health. Researchers with Johns Hopkins Medicine and computer scientists from Johns Hopkins University’s Whiting School of Engineering are analyzing thousands of abdominal scans in an effort to catch pancreatic tumors while they are still operable. Another computer scientist developed an
-Johns Hopkins UniversityThe Johns Hopkins Clinical Research Network (JHCRN) of the Johns Hopkins Institute for Clinical and Translational Research invites you to attend the 5th Annual Trends in Clinical Research Symposium, “Clinical Research by Learning from Clinical Practice: Facilitating through Technology and Collaboration”, Thursday, March 12, from 1:00 to 3 p.m. in Tilghman Auditorium. Keynote speaker, James
Founded on mutual interest rather than geographic proximity, the Sharing Partnership for Innovative Research in Translation (SPIRiT) Consortium links six CTSAs together to jointly develop innovative resources to support effective translational research. Consortium goals include promoting a sharing infrastructure for research data, tools, resources, and bio-specimens; establishing a network of
January 27, 2020The success of antiretroviral therapies has extended the lives of people living with HIV, long enough for other chronic health conditions to emerge, including a recently documented uptick in sudden death. Now, in a study comparing medical information and portable EKG patch data from men living with HIV to men without it, Johns Hopkins Medicine researchers and collaborators report they have found
January 27, 2020The last days and hours of 2019 marked not only the end of a decade, but also the completion of patient enrollment in a landmark randomized clinical trial on the duration of anti-clotting medication (anticoagulant) therapy for venous thromboembolism (VTE) in patients under 21 years old — the Kids-DOTT trial. VTE, which includes blood clots in the deep veins of the legs, arms, other areas of the
- December 04, 2019
Natural language processing, the technology that lets computers read, decipher, understand and make sense of human language, is the driving force behind internet search engines, email filters, digital assistants such as Amazon’s Alexa and Apple’s Siri, and language-to-language translation apps. Now, Johns Hopkins Medicine researchers say they have given this technology a new job as a clinical
- December 04, 2019
Face-jaw-teeth transplants are one of the most complicated surgeries due to differences between the donor and recipient. This month, the United States approved a patent submitted by a Johns Hopkins research team for a new way to perform facial transplants. The Computer Assisted Planning and Execution System (CAPE) method aids surgeons in planning and performing craniomaxillofacial surgery—a
September 19, 2019In a new study of seven people with Parkinson’s disease, Johns Hopkins Medicine researchers report evidence that deep brain stimulation using electrical impulses jumpstarts the nerve cells that produce the chemical messenger dopamine to reduce tremors and muscle rigidity that are the hallmark of Parkinson’s disease, and increases feelings of well-being. “While deep brain stimulation has been used
-Johns Hopkins UniversityJoin the Johns Hopkins Institute for Clinical & Translational Research in honoring the legacy of Mrs. Henrietta Lacks, Saturday, October 5 from 9:00 am to 12:30 pm, in Turner Auditorium, 720 Rutland Ave, 21205. This year, we celebrate the 10th Anniversary of the Henrietta Lacks Memorial Lecture. We are pleased to have Dr. Griffin Rodgers, director of the National Institutes of Diabetes and
Johns Hopkins UniversityThe CTSA Collaborative Data and Safety Monitoring Board (DSMB) Workgroup identified a need to provide guidance, training and resources in DSMB practices for investigator-initiated research studies. To promote clinical and translational research, the CTSA Collaborative DSMB Workgroup, supported by NCATS, has produced an online DSMB Training Manual with a focus on investigator-initiated studies
-
Applications of Innovative Methods in Health Equity Research: Health, Behavior, and Society Summer Institute (Johns Hopkins; Lisa Cooper, MD, MPH) Understand methods for overcoming challenges to conducting disparities research in underserved communities Learn new tools for data collection around hypertension disparities in African Americans Expand research network for studies related to
